AKT1 and neoplasm: Over the last decade, aberrancies of mTOR signaling have been reported in several types of solid tumors, especially CNS tumors, where the constitutive hyper-activation of the PI3K/Akt/mTOR pathway represents one of the major contributors of tumor initiation and progression [16,93].